Validating CGM for GDM

Phase

N/A

Condition

N/A

Treatment

Continuous glucose monitor

Clinical Study ID

NCT06858787

STUDY-25-00172

Ages 18-50
Female
Accepts Healthy Volunteers

Study Summary

This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Ages 18-50
Singleton pregnancy between 24-32 weeks gestational age
Prenatal care and delivery at Mount Sinai Hospital

Exclusion

Exclusion Criteria:

Multiple fetal gestation
Preexisting diabetes
Concurrent use of steroids
Anomalous fetus
Insufficient prenatal care (identified as missing half the recommended visits orestablishing care after 20 weeks gestation)
Unable to tolerate oral glucose test

Study Design

Continuous glucose monitor

October 02, 2025

April 30, 2028

Connect with a study center

Icahn School of Medicine at Mount Sinai
New York, New York 10029
United States
Site Not Available
Icahn School of Medicine at Mount Sinai
New York 5128581, New York 5128638 10029
United States
Active - Recruiting
Mount Sinai South Nassau
Oceanside 5129603, New York 5128638 11572
United States
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.